Fulgent Genetics, Inc. — insider transactions
3 transactions on record · FLGT · CIK 1674930
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$177K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$88.2K
2026-10-26
Director share, 12m
0.0%
of transactions where role is stated
Current run
3 sells
consecutive same-direction transactions
Net 3m flow
-$177K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | 2026-10-26 | 2 | Kim Paul | CFO and Treasurer | Shares withheld for tax | 2,748 | $20.22 | $55.6K | filing |
| 2026-10-28 | 2026-10-26 | 2 | Xie Jian | President and COO | Shares withheld for tax | 4,361 | $20.22 | $88.2K | filing |
| 2026-10-28 | 2026-10-26 | 2 | Gao Hanlin | Chief Scientific Officer | Shares withheld for tax | 1,645 | $20.22 | $33.3K | filing |